Comparison of luteal-phase support with high- and low-dose progesterone therapy on pregnancy rates in an in vitro fertilization program
- PMID: 1919266
- DOI: 10.1007/BF01131710
Comparison of luteal-phase support with high- and low-dose progesterone therapy on pregnancy rates in an in vitro fertilization program
Similar articles
-
Treatment of luteal phase defects in assisted reproduction.Curr Drug Targets. 2013 Jul;14(8):832-42. doi: 10.2174/1389450111314080002. Curr Drug Targets. 2013. PMID: 23621507 Review.
-
Human chorionic gonadotropin and intravaginal natural progesterone are equally effective for luteal phase support in IVF.Gynecol Endocrinol. 2000 Oct;14(5):316-20. doi: 10.3109/09513590009167699. Gynecol Endocrinol. 2000. PMID: 11109970 Clinical Trial.
-
Can we alter pregnancy outcome by adjusting progesterone treatment at mid-luteal phase: a randomized controlled trial.Gynecol Endocrinol. 2017 Aug;33(8):602-606. doi: 10.1080/09513590.2017.1298742. Epub 2017 Mar 9. Gynecol Endocrinol. 2017. PMID: 28277886 Clinical Trial.
-
Comparison of the efficacy of two vaginal progesterone formulations, Crinone 8% gel and Utrogestan capsules, used for luteal support in blastocyst stage embryo transfers.Taiwan J Obstet Gynecol. 2009 Dec;48(4):375-9. doi: 10.1016/S1028-4559(09)60326-0. Taiwan J Obstet Gynecol. 2009. PMID: 20045758 Clinical Trial.
-
Clinical use of progesterone in infertility and assisted reproduction.Acta Obstet Gynecol Scand. 2015 Nov;94 Suppl 161:17-27. doi: 10.1111/aogs.12770. Acta Obstet Gynecol Scand. 2015. PMID: 26345161 Review.
Cited by
-
Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.Pharm Res. 2018 Feb 14;35(3):62. doi: 10.1007/s11095-018-2357-x. Pharm Res. 2018. PMID: 29445971
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical